{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:22:14Z","timestamp":1791850934478,"version":"4.3.4"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2015,3,7]],"date-time":"2015-03-07T00:00:00Z","timestamp":1425686400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1007\/s00520-015-2678-9","type":"journal-article","created":{"date-parts":[[2015,3,6]],"date-time":"2015-03-06T01:27:38Z","timestamp":1425605258000},"page":"1473-1481","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Pharmacological options for the management of refractory cancer pain\u2014what is the evidence?"],"prefix":"10.1007","volume":"23","author":[{"given":"B.","family":"Afsharimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Kindl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Good","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,3,7]]},"reference":[{"key":"2678_CR1","doi-asserted-by":"crossref","unstructured":"Zech DF, Grond S, Lynch J, Hertel D, Lehmann KA (1995) Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study. Pain 63(1): 65\u201376","DOI":"10.1016\/0304-3959(95)00017-M"},{"issue":"6","key":"2678_CR2","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1177\/1049909108322288","volume":"25","author":"S Mishra","year":"2008","unstructured":"Mishra S, Bhatnagar S, Gupta D, Nirwani Goyal G, Jain R, Chauhan H (2008) Management of neuropathic cancer pain following WHO analgesic ladder: a prospective study. Am J Hosp Palliat Care 25(6):447\u201351","journal-title":"Am J Hosp Palliat Care"},{"issue":"1","key":"2678_CR3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/jpm.2011.0326","volume":"15","author":"DC Currow","year":"2012","unstructured":"Currow DC, Spruyt O, Hardy J (2012) Defining refractory pain in cancer for clinicians and researchers. J Palliat Med 15(1):5\u20136","journal-title":"J Palliat Med"},{"issue":"29","key":"2678_CR4","doi-asserted-by":"crossref","first-page":"3611","DOI":"10.1200\/JCO.2012.42.1081","volume":"30","author":"J Hardy","year":"2012","unstructured":"Hardy J, Quinn S, Fazekas B, Plummer J, Eckermann S, Agar M et al (2012) Double-blind, placebo-controlled study to assess the efficacy and toxicity of subcutaneous ketamine in the management of cancer pain. J Clin Oncol 30(29):3611\u20137","journal-title":"J Clin Oncol"},{"issue":"6","key":"2678_CR5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s00520-008-0423-3","volume":"16","author":"RL Fainsinger","year":"2008","unstructured":"Fainsinger RL, Nekolaichuk CL (2008) A \"TNM\" classification system for cancer pain: the Edmonton Classification System for Cancer Pain (ECS-CP). Support Care Cancer 16(6):547\u201355","journal-title":"Support Care Cancer"},{"issue":"6","key":"2678_CR6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/imj.12442","volume":"44","author":"JR Hardy","year":"2014","unstructured":"Hardy JR, Spruyt O, Quinn SJ, Devilee LR, Currow DC (2014) Implementing practice change in chronic cancer pain management\u2014clinician response to a phase III study of ketamine. J Intern Med 44(6):586\u201391","journal-title":"J Intern Med"},{"issue":"2","key":"2678_CR7","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1007\/s11916-013-0395-y","volume":"18","author":"S Mercadante","year":"2014","unstructured":"Mercadante S (2014) Managing difficult pain conditions in the cancer patient. Curr Pain Headache Rep 18(2):395","journal-title":"Curr Pain Headache Rep"},{"key":"2678_CR8","first-page":"Cd003868","volume":"7","author":"PJ Wiffen","year":"2013","unstructured":"Wiffen PJ, Wee B, Moore RA (2013) Oral morphine for cancer pain. Cochrane Database Syst Rev 7:Cd003868","journal-title":"Cochrane Database Syst Rev"},{"key":"2678_CR9","first-page":"Cd004311","volume":"10","author":"G Zeppetella","year":"2013","unstructured":"Zeppetella G, Davies AN (2013) Opioids for the management of breakthrough pain in cancer patients. Cochrane Database Syst Rev 10:Cd004311","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2678_CR10","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1080\/15360280802537225","volume":"22","author":"E McNicol","year":"2008","unstructured":"McNicol E (2008) Opioid side effects and their treatment in patients with chronic cancer and noncancer pain. J Pain Palliat Care Pharmacother 22(4):270\u201381","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"2","key":"2678_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0885-3924(95)00148-4","volume":"11","author":"CC Faura","year":"1996","unstructured":"Faura CC, Moore RA, Horga JF, Hand CW, McQuay HJ (1996) Morphine and morphine-6-glucuronide plasma concentrations and effect in cancer pain. J Pain Symptom Manag 11(2):95\u2013102","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"2678_CR12","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1191\/0269216303pm835oa","volume":"17","author":"P Klepstad","year":"2003","unstructured":"Klepstad P, Borchgrevink PC, Dale O, Zahlsen K, Aamo T, Fayers P et al (2003) Routine drug monitoring of serum concentrations of morphine, morphine-3-glucuronide and morphine-6-glucuronide do not predict clinical observations in cancer patients. J Palliat Med 17(8):679\u201387","journal-title":"J Palliat Med"},{"issue":"2","key":"2678_CR13","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1191\/0269216303pm658oa","volume":"17","author":"C Quigley","year":"2003","unstructured":"Quigley C, Joel S, Patel N, Baksh A, Slevin M (2003) Plasma concentrations of morphine, morphine-6-glucuronide and morphine-3-glucuronide and their relationship with analgesia and side effects in patients with cancer-related pain. J Palliat Med 17(2):185\u201390","journal-title":"J Palliat Med"},{"issue":"5","key":"2678_CR14","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1177\/0269216310383739","volume":"25","author":"L Radbruch","year":"2011","unstructured":"Radbruch L, Trottenberg P, Elsner F, Kaasa S, Caraceni A (2011) Systematic review of the role of alternative application routes for opioid treatment for moderate to severe cancer pain: an EPCRC opioid guidelines project. J Palliat Med 25(5):578\u201396","journal-title":"J Palliat Med"},{"issue":"2","key":"2678_CR15","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(12)70040-2","volume":"13","author":"A Caraceni","year":"2012","unstructured":"Caraceni A, Hanks G, Kaasa S, Bennett MI, Brunelli C, Cherny N et al (2012) Use of opioid analgesics in the treatment of cancer pain: evidence-based recommendations from the EAPC. Lancet Oncol 13(2):e58\u201368","journal-title":"Lancet Oncol"},{"issue":"4","key":"2678_CR16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/jpm.2005.8.743","volume":"8","author":"F Elsner","year":"2005","unstructured":"Elsner F, Radbruch L, Loick G, Gaertner J, Sabatowski R (2005) Intravenous versus subcutaneous morphine titration in patients with persisting exacerbation of cancer pain. J Palliat Med 8(4):743\u201350","journal-title":"J Palliat Med"},{"issue":"3","key":"2678_CR17","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1191\/0269216303pm695oa","volume":"17","author":"JT Harris","year":"2003","unstructured":"Harris JT, Suresh KK, Rajagopal MR (2003) Intravenous morphine for rapid control of severe cancer pain. J Palliat Med 17(3):248\u201356","journal-title":"J Palliat Med"},{"issue":"8","key":"2678_CR18","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.ejpain.2007.01.003","volume":"11","author":"S Mercadante","year":"2007","unstructured":"Mercadante S (2007) Opioid titration in cancer pain: a critical review. Eur J Pain (London, England) 11(8):823\u201330","journal-title":"Eur J Pain (London, England)"},{"issue":"2","key":"2678_CR19","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0885-3924(99)00051-2","volume":"18","author":"R Hunt","year":"1999","unstructured":"Hunt R, Fazekas B, Thorne D, Brooksbank M (1999) A comparison of subcutaneous morphine and fentanyl in hospice cancer patients. J Pain Symptom Manag 18(2):111\u20139","journal-title":"J Pain Symptom Manag"},{"issue":"3","key":"2678_CR20","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S0885-3924(03)00314-2","volume":"26","author":"LG Soares","year":"2003","unstructured":"Soares LG, Martins M, Uchoa R (2003) Intravenous fentanyl for cancer pain: a \"fast titration\" protocol for the emergency room. J Pain Symptom Manag 26(3):876\u201381","journal-title":"J Pain Symptom Manag"},{"issue":"5","key":"2678_CR21","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0885-3924(98)00095-5","volume":"16","author":"S Watanabe","year":"1998","unstructured":"Watanabe S, Pereira J, Hanson J, Bruera E (1998) Fentanyl by continuous subcutaneous infusion for the management of cancer pain: a retrospective study. J Pain Symptom Manag 16(5):323\u20136","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"2678_CR22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0304-3959(95)00084-6","volume":"63","author":"A Paix","year":"1995","unstructured":"Paix A, Coleman A, Lees J, Grigson J, Brooksbank M, Thorne D et al (1995) Subcutaneous fentanyl and sufentanil infusion substitution for morphine intolerance in cancer pain management. Pain 63(2):263\u20139","journal-title":"Pain"},{"issue":"2","key":"2678_CR23","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.1533-2500.2009.00335.x","volume":"10","author":"KC Vissers","year":"2010","unstructured":"Vissers KC, Besse K, Hans G, Devulder J, Morlion B (2010) Opioid rotation in the management of chronic pain: where is the evidence? Pain Pract 10(2):85\u201393","journal-title":"Pain Pract"},{"key":"2678_CR24","unstructured":"Quigley C (1996) Opioid switching to improve pain relief and drug tolerability. Cochrane Database Syst Rev (3):Cd004847"},{"issue":"5","key":"2678_CR25","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1177\/0269216310384902","volume":"25","author":"O Dale","year":"2011","unstructured":"Dale O, Moksnes K, Kaasa S (2011) European Palliative Care Research Collaborative pain guidelines: opioid switching to improve analgesia or reduce side effects. A systematic review. Palliat Med 25(5):494\u2013503","journal-title":"Palliat Med"},{"issue":"2\u20133","key":"2678_CR26","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0304-3959(99)00230-4","volume":"84","author":"FB Ross","year":"2000","unstructured":"Ross FB, Wallis SC, Smith MT (2000) Co-administration of sub-antinociceptive doses of oxycodone and morphine produces marked antinociceptive synergy with reduced CNS side-effects in rats. Pain 84(2\u20133):421\u20138","journal-title":"Pain"},{"key":"2678_CR27","doi-asserted-by":"crossref","unstructured":"Park SH, Park J, Kim YS, Hong J, Cho EK, Shin DB et al (2007) 1148 POSTER Opioid rotation versus combination for cancer patients with chronic uncontrolled pain: a study. Eur J Cancer Suppl 5(4):156","DOI":"10.1016\/S1359-6349(07)70667-5"},{"issue":"5","key":"2678_CR28","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0269216310392101","volume":"25","author":"MT Fallon","year":"2011","unstructured":"Fallon MT, Laird BJ (2011) A systematic review of combination step III opioid therapy in cancer pain: an EPCRC opioid guideline project. Palliat Med 25(5):597\u2013603","journal-title":"Palliat Med"},{"issue":"4","key":"2678_CR29","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s11912-006-0034-4","volume":"8","author":"J Bryson","year":"2006","unstructured":"Bryson J, Tamber A, Seccareccia D, Zimmermann C (2006) Methadone for treatment of cancer pain. Current Oncol Rep 8(4):282\u20138","journal-title":"Current Oncol Rep"},{"issue":"1","key":"2678_CR30","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1089\/10966210252785097","volume":"5","author":"E Bruera","year":"2002","unstructured":"Bruera E, Sweeney C (2002) Methadone use in cancer patients with pain: a review. J Palliat Med 5(1):127\u201338","journal-title":"J Palliat Med"},{"key":"2678_CR31","volume":"4","author":"AB Nicholson","year":"2007","unstructured":"Nicholson AB (2007) Methadone for cancer pain. Cochrane Database Syst Rev 4:CD003971","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2678_CR32","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/bjc.2012.593","volume":"108","author":"GR Lauretti","year":"2013","unstructured":"Lauretti GR, Rizzo CC, Mattos AL, Rodrigues SW (2013) Epidural methadone results in dose-dependent analgesia in cancer pain, further enhanced by epidural dexamethasone. Br J Cancer 108(2):259\u201364","journal-title":"Br J Cancer"},{"issue":"2","key":"2678_CR33","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00520-009-0649-8","volume":"18","author":"DI Cubero","year":"2010","unstructured":"Cubero DI, del Giglio A (2010) Early switching from morphine to methadone is not improved by acetaminophen in the analgesia of oncologic patients: a prospective, double-blind, placebo-controlled study. Support Care Cancer 18(2):235\u201342","journal-title":"Support Care Cancer"},{"issue":"5","key":"2678_CR34","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00520-008-0537-7","volume":"17","author":"W Leppert","year":"2009","unstructured":"Leppert W (2009) The role of methadone in opioid rotation\u2014a Polish experience. Support Care Cancer 17(5):607\u201312","journal-title":"Support Care Cancer"},{"issue":"1","key":"2678_CR35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00520-011-1259-9","volume":"20","author":"S Mercadante","year":"2012","unstructured":"Mercadante S, Ferrera P, Villari P, Adile C, Casuccio A (2012) Switching from oxycodone to methadone in advanced cancer patients. Support Care Cancer 20(1):191\u20134","journal-title":"Support Care Cancer"},{"issue":"4","key":"2678_CR36","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/MJT.0b013e31827ab599","volume":"20","author":"DW Berland","year":"2013","unstructured":"Berland DW, Malinoff HL, Weiner MA, Przybylski R (2013) When opioids fail in chronic pain management: the role for buprenorphine and hospitalization. Am J Ther 20(4):316\u201321","journal-title":"Am J Ther"},{"issue":"Suppl 1","key":"2678_CR37","doi-asserted-by":"crossref","first-page":"s25","DOI":"10.1191\/0269216306pm1125oa","volume":"20","author":"R Sittl","year":"2006","unstructured":"Sittl R (2006) Transdermal buprenorphine in cancer pain and palliative care. Palliat Med 20(Suppl 1):s25\u201330","journal-title":"Palliat Med"},{"issue":"5","key":"2678_CR38","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1185\/03007995.2012.678938","volume":"28","author":"RF Wolff","year":"2012","unstructured":"Wolff RF, Aune D, Truyers C, Hernandez AV, Misso K, Riemsma R et al (2012) Systematic review of efficacy and safety of buprenorphine versus fentanyl or morphine in patients with chronic moderate to severe pain. Curr Med Res Opin 28(5):833\u201345","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2678_CR39","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S0149-2918(03)90019-1","volume":"25","author":"R Sittl","year":"2003","unstructured":"Sittl R, Griessinger N, Likar R (2003) Analgesic efficacy and tolerability of transdermal buprenorphine in patients with inadequately controlled chronic pain related to cancer and other disorders: a multicenter, double-blind, placebo-controlled trial. Clin Ther 25(1):150\u201368","journal-title":"Clin Ther"},{"issue":"11","key":"2678_CR40","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/j.clinthera.2004.11.008","volume":"26","author":"J Sorge","year":"2004","unstructured":"Sorge J, Sittl R (2004) Transdermal buprenorphine in the treatment of chronic pain: Results of a phase III, multicenter, double-blind, placebo-controlled study. Clin Ther 26(11):1808\u201320","journal-title":"Clin Ther"},{"issue":"2","key":"2678_CR41","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jpainsymman.2007.09.011","volume":"36","author":"P Poulain","year":"2008","unstructured":"Poulain P, Denier W, Douma J, Hoerauf K, Samija M, Sopata M et al (2008) Efficacy and safety of transdermal buprenorphine: a, placebo-controlled trial in 289 patients with severe cancer pain. J Pain Symptom Manag 36(2):117\u201325","journal-title":"J Pain Symptom Manag"},{"issue":"8","key":"2678_CR42","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1185\/030079905X53315","volume":"21","author":"N Griessinger","year":"2005","unstructured":"Griessinger N, Sittl R, Likar R (2005) Transdermal buprenorphine in clinical practice\u2014a post-marketing surveillance study in 13,179 patients. Curr Med Res Opin 21(8):1147\u201356","journal-title":"Curr Med Res Opin"},{"key":"2678_CR43","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.2741\/2147","volume":"12","author":"MC Pace","year":"2007","unstructured":"Pace MC, Passavanti MB, Grella E, Mazzariello L, Maisto M, Barbarisi M et al (2007) Buprenorphine in long-term control of chronic pain in cancer patients. Front Biosci 12:1291\u20139","journal-title":"Front Biosci"},{"issue":"6","key":"2678_CR44","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1185\/03007990902920731","volume":"25","author":"JV Pergolizzi Jr","year":"2009","unstructured":"Pergolizzi JV Jr, Mercadante S, Echaburu AV, Van den Eynden B, Fragoso RM, Mordarski S et al (2009) The role of transdermal buprenorphine in the treatment of cancer pain: an expert panel consensus. Curr Med Res Opin 25(6):1517\u201328","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"2678_CR45","first-page":"707","volume":"5","author":"S Deandrea","year":"2009","unstructured":"Deandrea S, Corli O, Moschetti I, Apolone G (2009) Managing severe cancer pain: the role of transdermal buprenorphine: a systematic review. Ther Clin Risk Manag 5(1):707\u201318","journal-title":"Ther Clin Risk Manag"},{"issue":"4","key":"2678_CR46","first-page":"S120","volume":"24","author":"D Tassinari","year":"2010","unstructured":"Tassinari D, Maltoni M (2010) Systematic review on the role of transdermal BUPRENORPHINE (TB) for moderate to severe cancer pain: an EPCRC opioid guidelines project. Palliat Med 24(4):S120","journal-title":"Palliat Med"},{"key":"2678_CR47","unstructured":"World Health Organization (1996) Cancer Pain Relief. 2nd ed. Geneva, Switzerland"},{"issue":"4","key":"2678_CR48","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1177\/0269216311428528","volume":"26","author":"M Nabal","year":"2012","unstructured":"Nabal M, Librada S, Redondo MJ, Pigni A, Brunelli C, Caraceni A (2012) The role of paracetamol and nonsteroidal anti-inflammatory drugs in addition to WHO Step III opioids in the control of pain in advanced cancer\u2014a systematic review of the literature. Palliat Med 26(4):305\u201312","journal-title":"Palliat Med"},{"issue":"16","key":"2678_CR49","first-page":"2129","volume":"17","author":"F Franceschi","year":"2013","unstructured":"Franceschi F, Iacomini P, Marsiliani D, Cordischi C, Antonini EF, Alesi A et al (2013) Safety and efficacy of the combination acetaminophen-codeine in the treatment of pain of different origin. Eur Rev Med Pharmacol Sci 17(16):2129\u201335","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2678_CR50","volume":"1","author":"E McNicol","year":"2005","unstructured":"McNicol E, Strassels SA, Goudas L, Lau J, Carr DB (2005) NSAIDS or paracetamol, alone or combined with opioids, for cancer pain. Cochrane Database Syst Rev 1:CD005180","journal-title":"Cochrane Database Syst Rev"},{"key":"2678_CR51","doi-asserted-by":"crossref","unstructured":"Mercadante S, Fulfaro F, Casuccio A (2002) A controlled study on the use of anti-inflammatory drugs in patients with cancer pain on morphine therapy: effects on dose-escalation and a pharmacoeconomic analysis. Eur J Cancer 38(10):1358\u201363","DOI":"10.1016\/S0959-8049(02)00102-8"},{"issue":"11","key":"2678_CR52","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1007\/s00520-007-0327-7","volume":"15","author":"JF Duarte Souza","year":"2007","unstructured":"Duarte Souza JF, Lajolo PP, Pinczowski H, del Giglio A (2007) Adjunct dipyrone in association with oral morphine for cancer-related pain: the sooner the better. Support Care Cancer 15(11):1319\u201323","journal-title":"Support Care Cancer"},{"issue":"18","key":"2678_CR53","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.2165\/0003495-200868180-00007","volume":"68","author":"B Verdu","year":"2008","unstructured":"Verdu B, Decosterd I, Buclin T, Stiefel F, Berney A (2008) Antidepressants for the treatment of chronic pain. Drugs 68(18):2611\u201332","journal-title":"Drugs"},{"key":"2678_CR54","doi-asserted-by":"crossref","unstructured":"Saarto T, Wiffen PJ (2007) Antidepressants for neuropathic pain. Cochrane Database Syst Rev 4:CD005454","DOI":"10.1002\/14651858.CD005454.pub2"},{"key":"2678_CR55","first-page":"Cd008242","volume":"12","author":"RA Moore","year":"2012","unstructured":"Moore RA, Derry S, Aldington D, Cole P, Wiffen PJ (2012) Amitriptyline for neuropathic pain and fibromyalgia in adults. Cochrane Database Syst Rev 12:Cd008242","journal-title":"Cochrane Database Syst Rev"},{"issue":"Suppl","key":"2678_CR56","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.clinthera.2007.12.002","volume":"29","author":"DK Kajdasz","year":"2007","unstructured":"Kajdasz DK, Iyengar S, Desaiah D, Backonja MM, Farrar JT, Fishbain DA et al (2007) Duloxetine for the management of diabetic peripheral neuropathic pain: evidence-based findings from post hoc analysis of three multicenter, double-blind, placebo-controlled, parallel-group studies. Clin Ther 29(Suppl):2536\u201346","journal-title":"Clin Ther"},{"issue":"2","key":"2678_CR57","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.jpainsymman.2003.06.004","volume":"27","author":"SS Reuben","year":"2004","unstructured":"Reuben SS, Makari-Judson G, Lurie SD (2004) Evaluation of efficacy of the perioperative administration of venlafaxine XR in the prevention of postmastectomy pain syndrome. J Pain Symptom Manag 27(2):133\u20139","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"2678_CR58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1053\/eujp.2001.0266","volume":"6","author":"T Tasmuth","year":"2002","unstructured":"Tasmuth T, Hartel B, Kalso E (2002) Venlafaxine in neuropathic pain following treatment of breast cancer. Eur J Pain 6(1):17\u201324","journal-title":"Eur J Pain"},{"issue":"2","key":"2678_CR59","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/0304-3959(95)00138-7","volume":"64","author":"E Kalso","year":"1996","unstructured":"Kalso E, Tasmuth T, Neuvonen PJ (1996) Amitriptyline effectively relieves neuropathic pain following treatment of breast cancer. Pain 64(2):293\u2013302","journal-title":"Pain"},{"issue":"3","key":"2678_CR60","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1177\/030089160208800310","volume":"88","author":"S Mercadante","year":"2002","unstructured":"Mercadante S, Arcuri E, Tirelli W, Villari P, Casuccio A (2002) Amitriptyline in neuropathic cancer pain in patients on morphine therapy: a placebo-controlled, double-blind crossover study. Tumori 88(3):239\u201342","journal-title":"Tumori"},{"issue":"5","key":"2678_CR61","first-page":"E547","volume":"16","author":"M Nishihara","year":"2013","unstructured":"Nishihara M, Arai YC, Yamamoto Y, Nishida K, Arakawa M, Ushida T et al (2013) Combinations of low-dose antidepressants and low-dose pregabalin as useful adjuvants to opioids for intractable, painful bone metastases. Pain Physician 16(5):E547\u201352","journal-title":"Pain Physician"},{"key":"2678_CR62","doi-asserted-by":"crossref","unstructured":"Smith EM, Pang H, Cirrincione C, Fleishman S, Paskett ED, Ahles T et al (2013) Effect of duloxetine on pain, function, and quality of life among patients with chemotherapy-induced painful peripheral neuropathy: a clinical trial. JAMA 309(13):1359\u201367","DOI":"10.1001\/jama.2013.2813"},{"key":"2678_CR63","doi-asserted-by":"crossref","unstructured":"Jongen JLM, Huijsman ML, Jessurun J, Ogenio K, Schipper D, Verkouteren DRC et al (2013) The evidence for pharmacologic treatment of neuropathic cancer pain: beneficial and adverse effects. J Pain Symptom Manag 46(4):581\u201390","DOI":"10.1016\/j.jpainsymman.2012.10.230"},{"issue":"3","key":"2678_CR64","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pain.2007.08.033","volume":"132","author":"RH Dworkin","year":"2007","unstructured":"Dworkin RH, O\u2019Connor AB, Backonja M, Farrar JT, Finnerup NB, Jensen TS et al (2007) Pharmacologic management of neuropathic pain: evidence-based recommendations. Pain 132(3):237\u201351","journal-title":"Pain"},{"issue":"1","key":"2678_CR65","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.coph.2005.11.003","volume":"6","author":"GJ Sills","year":"2006","unstructured":"Sills GJ (2006) The mechanisms of action of gabapentin and pregabalin. Curr Opin Pharmacol 6(1):108\u201313","journal-title":"Curr Opin Pharmacol"},{"issue":"5","key":"2678_CR66","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1177\/0269216310378546","volume":"25","author":"MI Bennett","year":"2011","unstructured":"Bennett MI (2011) Effectiveness of antiepileptic or antidepressant drugs when added to opioids for cancer pain: systematic review. Palliat Med 25(5):553\u20139","journal-title":"Palliat Med"},{"issue":"4","key":"2678_CR67","doi-asserted-by":"crossref","first-page":"334","DOI":"10.4103\/0253-7613.115000","volume":"45","author":"M Banerjee","year":"2013","unstructured":"Banerjee M, Pal S, Bhattacharya B, Ghosh B, Mondal S, Basu J (2013) A comparative study of efficacy and safety of gabapentin versus amitriptyline as coanalgesics in patients receiving opioid analgesics for neuropathic pain in malignancy. Indian J Pharmacol 45(4):334\u20138","journal-title":"Indian J Pharmacol"},{"issue":"14","key":"2678_CR68","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1200\/JCO.2004.08.141","volume":"22","author":"A Caraceni","year":"2004","unstructured":"Caraceni A, Zecca E, Bonezzi C, Arcuri E, Yaya Tur R, Maltoni M et al (2004) Gabapentin for neuropathic cancer pain: a controlled trial from the Gabapentin Cancer Pain Study Group. J Clin Oncol 22(14):2909\u201317","journal-title":"J Clin Oncol"},{"issue":"3","key":"2678_CR69","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1049909111412539","volume":"29","author":"S Mishra","year":"2012","unstructured":"Mishra S, Bhatnagar S, Goyal GN, Rana SP, Upadhya SP (2012) A comparative efficacy of amitriptyline, gabapentin, and pregabalin in neuropathic cancer pain: a prospective double-blind placebo-controlled study. Am J Hosp Palliat Care 29(3):177\u201382","journal-title":"Am J Hosp Palliat Care"},{"key":"2678_CR70","doi-asserted-by":"crossref","unstructured":"Raptis E, Vadalouca A, Stavropoulou E, Argyra E, Melemeni A, Siafaka I (2014) Pregabalin Vs Opioids for the Treatment of Neuropathic Cancer Pain: A Prospective, Head-to-Head, Open-Label Study. Pain Pract 14(1): 32\u201342","DOI":"10.1111\/papr.12045"},{"issue":"11","key":"2678_CR71","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/pme.12212","volume":"14","author":"MI Bennett","year":"2013","unstructured":"Bennett MI, Laird B, van Litsenburg C, Nimour M (2013) Pregabalin for the management of neuropathic pain in adults with cancer: a systematic review of the literature. Pain Med 14(11):1681\u20138","journal-title":"Pain Med"},{"issue":"4","key":"2678_CR72","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/jpm.2011.0244","volume":"15","author":"EE Prommer","year":"2012","unstructured":"Prommer EE (2012) Ketamine for pain: an update of uses in palliative care. J Palliat Med 15(4):474\u201383","journal-title":"J Palliat Med"},{"issue":"3","key":"2678_CR73","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1177\/082585971002600306","volume":"26","author":"K Jackson","year":"2010","unstructured":"Jackson K, Ashby M, Howell D, Petersen J, Brumley D, Good P et al (2010) The effectiveness and adverse effects profile of \"burst\" ketamine in refractory cancer pain: the VCOG PM 1\u201300 study. J Palliat Care 26(3):176\u201383","journal-title":"J Palliat Care"},{"issue":"4","key":"2678_CR74","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0885-3924(00)00194-9","volume":"20","author":"S Mercadante","year":"2000","unstructured":"Mercadante S, Arcuri E, Tirelli W, Casuccio A (2000) Analgesic effect of intravenous ketamine in cancer patients on morphine therapy: a, controlled, double-blind, crossover, double-dose study. J Pain Symptom Manag 20(4):246\u201352","journal-title":"J Pain Symptom Manag"},{"issue":"4","key":"2678_CR75","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/BF03011718","volume":"43","author":"CY Yang","year":"1996","unstructured":"Yang CY, Wong CS, Chang JY, Ho ST (1996) Intrathecal ketamine reduces morphine requirements in patients with terminal cancer pain. Can J Anaesth 43(4):379\u201383","journal-title":"Can J Anaesth"},{"key":"2678_CR76","first-page":"Cd003351","volume":"11","author":"RF Bell","year":"2012","unstructured":"Bell RF, Eccleston C, Kalso EA (2012) Ketamine as an adjuvant to opioids for cancer pain. Cochrane Database Syst Rev 11:Cd003351","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"2678_CR77","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/jpm.2011.0353","volume":"15","author":"S Salas","year":"2012","unstructured":"Salas S, Frasca M, Planchet-Barraud B, Burucoa B, Pascal M, Lapiana JM et al (2012) Ketamine analgesic effect by continuous intravenous infusion in refractory cancer pain: considerations about the clinical research in palliative care. J Palliat Med 15(3):287\u201393","journal-title":"J Palliat Med"},{"issue":"4","key":"2678_CR78","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/1049909111416345","volume":"29","author":"E Soto","year":"2012","unstructured":"Soto E, Stewart DR, Mannes AJ, Ruppert SL, Baker K, Zlott D et al (2012) Oral ketamine in the palliative care setting: a review of the literature and case report of a patient with neurofibromatosis type 1 and glomus tumor-associated complex regional pain syndrome. Am J Hosp Palliat Care 29(4):308\u201317","journal-title":"Am J Hosp Palliat Care"},{"key":"2678_CR79","doi-asserted-by":"crossref","unstructured":"Bredlau AL, Thakur R, Korones DN, Dworkin RH (2013) Ketamine for Pain in Adults and Children with Cancer: A Systematic Review and Synthesis of the Literature. Pain Med 14(10):1505\u201317","DOI":"10.1111\/pme.12182"},{"issue":"5","key":"2678_CR80","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","volume":"72","author":"ME Lynch","year":"2011","unstructured":"Lynch ME, Campbell F (2011) Cannabinoids for treatment of chronic non-cancer pain; a systematic review of trials. Br J Clin Pharmacol 72(5):735\u201344","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"2678_CR81","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2174\/157015906778019527","volume":"4","author":"J Manzanares","year":"2006","unstructured":"Manzanares J, Julian M, Carrascosa A (2006) Role of the cannabinoid system in pain control and therapeutic implications for the management of acute and chronic pain episodes. Curr Neuropharmacol 4(3):239\u201357","journal-title":"Curr Neuropharmacol"},{"issue":"2","key":"2678_CR82","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/cpt1978242223","volume":"24","author":"PR Jochimsen","year":"1978","unstructured":"Jochimsen PR, Lawton RL, VerSteeg K, Noyes R Jr (1978) Effect of benzopyranoperidine, a delta-9-THC congener, on pain. Clin Pharmacol Ther 24(2):223\u20137","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"2678_CR83","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/cpt1978234397","volume":"23","author":"M Staquet","year":"1978","unstructured":"Staquet M, Gantt C, Machin D (1978) Effect of a nitrogen analog of tetrahydrocannabinol on cancer pain. Clin Pharmacol Ther 23(4):397\u2013401","journal-title":"Clin Pharmacol Ther"},{"issue":"3","key":"2678_CR84","first-page":"119","volume":"6","author":"V Maida","year":"2008","unstructured":"Maida V, Ennis M, Irani S, Corbo M, Dolzhykov M (2008) Adjunctive nabilone in cancer pain and symptom management: a prospective observational study using propensity scoring. J Support Oncol 6(3):119\u201324","journal-title":"J Support Oncol"},{"issue":"8","key":"2678_CR85","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/cbdv.200790150","volume":"4","author":"EB Russo","year":"2007","unstructured":"Russo EB, Guy GW, Robson PJ (2007) Cannabis, pain, and sleep: lessons from therapeutic clinical trials of Sativex, a cannabis-based medicine. Chem Biodivers 4(8):1729\u201343","journal-title":"Chem Biodivers"},{"issue":"5","key":"2678_CR86","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jpain.2012.01.003","volume":"13","author":"RK Portenoy","year":"2012","unstructured":"Portenoy RK, Ganae-Motan ED, Allende S, Yanagihara R, Shaiova L, Weinstein S et al (2012) Nabiximols for opioid-treated cancer patients with poorly-controlled chronic pain: a randomized, placebo-controlled, graded-dose trial. J Pain 13(5):438\u201349","journal-title":"J Pain"},{"issue":"2","key":"2678_CR87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jpainsymman.2009.06.008","volume":"39","author":"JR Johnson","year":"2010","unstructured":"Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT (2010) Multicenter, double-blind, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manag 39(2):167\u201379","journal-title":"J Pain Symptom Manag"},{"issue":"2","key":"2678_CR88","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jpainsymman.2012.07.014","volume":"46","author":"JR Johnson","year":"2013","unstructured":"Johnson JR, Lossignol D, Burnell-Nugent M, Fallon MT (2013) An open-label extension study to investigate the long-term safety and tolerability of THC\/CBD oromucosal spray and oromucosal THC spray in patients with terminal cancer-related pain refractory to strong opioid analgesics. J Pain Symptom Manag 46(2):207\u201318","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"2678_CR89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","volume":"111","author":"MT Fallon","year":"2013","unstructured":"Fallon MT (2013) Neuropathic pain in cancer. Br J Anaesth 111(1):105\u201311","journal-title":"Br J Anaesth"},{"issue":"6","key":"2678_CR90","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1213\/01.ANE.0000186348.86792.38","volume":"101","author":"IW Tremont-Lukats","year":"2005","unstructured":"Tremont-Lukats IW, Challapalli V, McNicol ED, Lau J, Carr DB (2005) Systemic administration of local anesthetics to relieve neuropathic pain: a systematic review and meta-analysis. Anesth Analg 101(6):1738\u201349","journal-title":"Anesth Analg"},{"key":"2678_CR91","volume":"4","author":"V Challapalli","year":"2005","unstructured":"Challapalli V, Tremont-Lukats IW, McNicol ED, Lau J, Carr DB (2005) Systemic administration of local anesthetic agents to relieve neuropathic pain. Cochrane Database Syst Rev 4, CD003345","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"2678_CR92","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/0885-3924(94)90200-3","volume":"9","author":"S Watanabe","year":"1994","unstructured":"Watanabe S, Bruera E (1994) Corticosteroids as adjuvant analgesics. J Pain Symptom Manag 9(7):442\u20135","journal-title":"J Pain Symptom Manag"},{"issue":"1","key":"2678_CR93","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","volume":"46","author":"\u00d8 Paulsen","year":"2013","unstructured":"Paulsen \u00d8, Aass N, Kaasa S, Dale O (2013) Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review. J Pain Symptom Manag 46(1):96\u2013105","journal-title":"J Pain Symptom Manag"},{"issue":"12","key":"2678_CR94","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/0277-5379(89)90353-2","volume":"25","author":"GR Della Cuna","year":"1989","unstructured":"Della Cuna GR, Pellegrini A, Piazzi M (1989) Effect of methylprednisolone sodium succinate on quality of life in preterminal cancer patients: a placebo-controlled, multicenter study. The Methylprednisolone Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 25(12):1817\u201321","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"12","key":"2678_CR95","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/0277-5379(89)90354-4","volume":"25","author":"T Popiela","year":"1989","unstructured":"Popiela T, Lucchi R, Giongo F (1989) Methylprednisolone as palliative therapy for female terminal cancer patients. The Methylprednisolone Female Preterminal Cancer Study Group. Eur J Cancer Clin Oncol 25(12):1823\u20139","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"7\u20138","key":"2678_CR96","first-page":"751","volume":"69","author":"E Bruera","year":"1985","unstructured":"Bruera E, Roca E, Cedaro L, Carraro S, Chacon R (1985) Action of oral methylprednisolone in terminal cancer patients: a prospective randomized double-blind study. Cancer Treat Rep 69(7\u20138):751\u20134","journal-title":"Cancer Treat Rep"},{"issue":"4","key":"2678_CR97","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jpainsymman.2004.01.009","volume":"28","author":"E Bruera","year":"2004","unstructured":"Bruera E, Moyano JR, Sala R, Rico MA, Bosnjak S, Bertolino M et al (2004) Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a controlled trial. J Pain Symptom Manag 28(4):381\u20138","journal-title":"J Pain Symptom Manag"},{"key":"2678_CR98","doi-asserted-by":"crossref","unstructured":"Paulsen O, Klepstad P, Rosland JH, Aass N, Albert E, Fayers P, et al. (2014) Efficacy of Methylprednisolone on Pain, Fatigue, and Appetite Loss in Patients With Advanced Cancer Using Opioids: A, Placebo-Controlled, Double-Blind Trial. J Clin Oncol 32(29):3221\u20138","DOI":"10.1200\/JCO.2013.54.3926"},{"issue":"4","key":"2678_CR99","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/FPC.0000000000000032","volume":"24","author":"DT Barratt","year":"2014","unstructured":"Barratt DT, Bandak B, Klepstad P, Dale O, Kaasa S, Christrup LL et al (2014) Genetic, pathological and physiological determinants of transdermal fentanyl pharmacokinetics in 620 cancer patients of the EPOS study. Pharmacogenet Genomics 24(4):185\u201394","journal-title":"Pharmacogenet Genomics"},{"issue":"2","key":"2678_CR100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0304-3959(92)90256-B","volume":"51","author":"MA Ashby","year":"1992","unstructured":"Ashby MA, Fleming BG, Brooksbank M, Rounsefell B, Runciman WB, Jackson K et al (1992) Description of a mechanistic approach to pain management in advanced cancer. Preliminary report. Pain 51(2):153\u201361","journal-title":"Pain"},{"issue":"1","key":"2678_CR101","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1445-5994.2004.00727.x","volume":"35","author":"P Good","year":"2005","unstructured":"Good P, Tullio F, Jackson K, Goodchild C, Ashby M (2005) Prospective audit of short-term concurrent ketamine, opioid and anti-inflammatory ('triple-agent') therapy for episodes of acute on chronic pain. Intern Med J 35(1):39\u201344","journal-title":"Intern Med J"},{"issue":"2","key":"2678_CR102","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(01)00349-9","volume":"94","author":"JT Farrar","year":"2001","unstructured":"Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94(2):149\u201358","journal-title":"Pain"},{"issue":"Suppl 1","key":"2678_CR103","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.6004\/jnccn.2013.0212","volume":"11","author":"PA Glare","year":"2013","unstructured":"Glare PA (2013) Early implementation of palliative care can improve patient outcomes. J Natl Compr Canc Netw 11(Suppl 1):S3\u20139","journal-title":"J Natl Compr Canc Netw"},{"issue":"5","key":"2678_CR104","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s00520-012-1665-7","volume":"21","author":"S Mercadante","year":"2013","unstructured":"Mercadante S, Giardina P (2013) Can a phone call be more effective than an intrathecal implanted pump? Support Care Cancer 21(5):1213\u20135","journal-title":"Support Care Cancer"},{"issue":"1","key":"2678_CR105","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jpainsymman.2011.07.010","volume":"44","author":"A Reddy","year":"2012","unstructured":"Reddy A, Hui D, Bruera E (2012) A successful palliative care intervention for cancer pain refractory to intrathecal analgesia. J Pain Symptom Manag 44(1):124\u201330","journal-title":"J Pain Symptom Manag"},{"key":"2678_CR106","doi-asserted-by":"crossref","unstructured":"Kaasa S, Apolone G, Klepstad P, Havard Loge J et al (2011) Expert conference on cancer pain assessment and classification\u2014the need for international consensus: working proposals on international standards. BMJ Support Palliat Care 1(3):281\u2013287","DOI":"10.1136\/bmjspcare-2011-000078"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2678-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00520-015-2678-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-015-2678-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T11:10:43Z","timestamp":1651403443000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00520-015-2678-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,7]]},"references-count":106,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["2678"],"URL":"https:\/\/doi.org\/10.1007\/s00520-015-2678-9","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,7]]}}}